{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:50:15Z","timestamp":1770990615285,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.canlet.2004.11.039","type":"journal-article","created":{"date-parts":[[2004,12,29]],"date-time":"2004-12-29T19:16:50Z","timestamp":1104347810000},"page":"27-35","source":"Crossref","is-referenced-by-count":56,"title":["Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo"],"prefix":"10.1016","volume":"226","author":[{"given":"Yu-Ping","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Beger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming W.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2004.11.039_bib1","series-title":"Chemistry and Toxicology of Pyrrolizidine Alkaloids","author":"Mattocks","year":"1986"},{"key":"10.1016\/j.canlet.2004.11.039_bib2","first-page":"83","article-title":"Medicinal plants in Europe containing pyrrolizidine alkaloids","volume":"50","author":"Roeder","year":"1995","journal-title":"Pharmazie"},{"key":"10.1016\/j.canlet.2004.11.039_bib3","first-page":"711","article-title":"Medicinal plants in China containing pyrrolizidine alkaloids","volume":"55","author":"Roeder","year":"2000","journal-title":"Pharmazie"},{"key":"10.1016\/j.canlet.2004.11.039_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/taap.1998.8552","article-title":"Pyrrolizidine alkaloids crosslink DNA with actin","volume":"154","author":"Coulombe","year":"1999","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.canlet.2004.11.039_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1081\/GNC-100107580","article-title":"Genotoxic pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides\u2014mechanisms leading to DNA adduct formation and tumorigenicity","volume":"C19","author":"Fu","year":"2001","journal-title":"Environ. Carcinogen. Ecotoxicol. Rev."},{"key":"10.1016\/j.canlet.2004.11.039_bib6","first-page":"5","article-title":"Pyrrolizidine alkaloid plants, metabolism and toxicity","volume":"8","author":"Stegelmeier","year":"1999","journal-title":"J. Nat. Toxins"},{"key":"10.1016\/j.canlet.2004.11.039_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0041-008X(91)90137-4","article-title":"DNA cross-linking in mammalian cells by pyrrolizidine alkaloids: structure\u2013activity relationships","volume":"111","author":"Hincks","year":"1991","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.canlet.2004.11.039_bib8","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1093\/carcin\/16.11.2691","article-title":"Pyrrolizidine alkaloid-induced DNA\u2013protein cross-links","volume":"16","author":"Kim","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2004.11.039_bib9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/carcin\/9.8.1355","article-title":"Crosslinking of DNA by dehydroretronecine, a metabolite of pyrrolizidine alkaloids","volume":"9","author":"Reed","year":"1988","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2004.11.039_bib10","unstructured":"NTP Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344\/N rats and B6C3F1 mice (gavage studies), Technical Report Series No 508, National Toxicology Program, Research Triangle Park, NC, 2003."},{"key":"10.1016\/j.canlet.2004.11.039_bib11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0041-008X(86)90349-2","article-title":"Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity","volume":"85","author":"Bruner","year":"1986","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.canlet.2004.11.039_bib12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/978-1-4684-5877-0_64","article-title":"Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite","volume":"283","author":"Roth","year":"1991","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.canlet.2004.11.039_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-7992(92)90091-U","article-title":"The clastogenic potential in vitro of pyrrolizidine alkaloids employing hepatocyte metabolism","volume":"282","author":"Muller","year":"1992","journal-title":"Mutat. Res."},{"key":"10.1016\/j.canlet.2004.11.039_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/10408449209146311","article-title":"Mechanisms and pathology of monocrotaline pulmonary toxicity","volume":"22","author":"Wilson","year":"1992","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.canlet.2004.11.039_bib15","first-page":"461","article-title":"Micronucleus formation in human lymphocytes and in the metabolically competent human hepatoma cell line Hep-G2: results with 15 naturally occurring substances","volume":"21","author":"Kevekordes","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2004.11.039_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0378-4274(03)00240-6","article-title":"Toxicity and carcinogenicity of riddelliine in rats and mice","volume":"144","author":"Chan","year":"2003","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.canlet.2004.11.039_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/tx000150n","article-title":"Metabolic activation of the tumorigenic pyrrolizidine alkalois, riddelliine, leading to DNA adduct formation in vivo","volume":"14","author":"Yang","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.canlet.2004.11.039_bib18","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1021\/tx030018y","article-title":"Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid, in vitro and in vivo","volume":"16","author":"Chou","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.canlet.2004.11.039_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3835(03)00045-4","article-title":"Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F1 mice","volume":"193","author":"Chou","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2004.11.039_bib20","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/tx049955b","article-title":"Mutations induced by riddelliine, a carcinogenic pyrrolizidine alkaloid, in the liver cII2 gene of Big Blue transgenic rats","volume":"17","author":"Mei","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.canlet.2004.11.039_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/tx000149o","article-title":"Development of a 32P-postlabeling\/ HPLC method for detection of dehydroretronesine-derived DNA adducts in vitro and in vivo","volume":"14","author":"Yang","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.canlet.2004.11.039_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-4274(03)00293-5","article-title":"Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine","volume":"145","author":"Chou","year":"2003","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.canlet.2004.11.039_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0009-2797(90)90031-H","article-title":"Trapping and measurement of short-lived alkylating agents in a recirculating flow system","volume":"76","author":"Mattocks","year":"1990","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.canlet.2004.11.039_bib24","first-page":"605","article-title":"Sulfur conjugates as putative pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline","volume":"vol. 4","author":"Huxtable","year":"1991"},{"key":"10.1016\/j.canlet.2004.11.039_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/taap.1995.1017","article-title":"Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver","volume":"130","author":"Yan","year":"1995","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.canlet.2004.11.039_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1099-0461(1998)12:3<157::AID-JBT4>3.0.CO;2-K","article-title":"Involvement of cytochrome P450 3A in the metabolism and covalent binding of 14C-monocrotaline in rat liver microsomes","volume":"12","author":"Reid","year":"1998","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.canlet.2004.11.039_bib27","series-title":"The Pyrrolizidine Alkaloids. Their Chemistry, Pathogenicity and other Biological Properties","author":"Bull","year":"1968"},{"key":"10.1016\/j.canlet.2004.11.039_bib28","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.2527\/jas1988.6692343x","article-title":"Toxicity and metabolism of pyrrolizidine alkaloids","volume":"66","author":"Cheeke","year":"1988","journal-title":"J. Anim. Sci."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383504009334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383504009334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T09:22:56Z","timestamp":1548840176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383504009334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0304383504009334"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2004.11.039","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}